Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.
A crucial aspect in data collection and analysis is the employment of proxies. specifically, residential proxies are of paramount significance. The role of these technologies has increased in recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback